Core Alternative Capital Has $9.94 Million Position in UnitedHealth Group Incorporated (NYSE:UNH)

Core Alternative Capital cut its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 13.8% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 18,972 shares of the healthcare conglomerate's stock after selling 3,038 shares during the period. UnitedHealth Group makes up approximately 2.4% of Core Alternative Capital's holdings, making the stock its 7th biggest position. Core Alternative Capital's holdings in UnitedHealth Group were worth $9,937,000 as of its most recent SEC filing.

Other hedge funds have also recently added to or reduced their stakes in the company. Brighton Jones LLC lifted its position in shares of UnitedHealth Group by 176.2% in the 4th quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate's stock valued at $22,384,000 after acquiring an additional 28,231 shares in the last quarter. Revolve Wealth Partners LLC lifted its holdings in shares of UnitedHealth Group by 137.1% in the fourth quarter. Revolve Wealth Partners LLC now owns 4,019 shares of the healthcare conglomerate's stock valued at $2,033,000 after purchasing an additional 2,324 shares in the last quarter. Bank Pictet & Cie Europe AG grew its holdings in shares of UnitedHealth Group by 3.9% during the fourth quarter. Bank Pictet & Cie Europe AG now owns 263,655 shares of the healthcare conglomerate's stock valued at $133,373,000 after buying an additional 9,872 shares in the last quarter. Proficio Capital Partners LLC raised its position in UnitedHealth Group by 52.1% during the fourth quarter. Proficio Capital Partners LLC now owns 3,734 shares of the healthcare conglomerate's stock valued at $1,889,000 after buying an additional 1,279 shares during the period. Finally, Welch & Forbes LLC boosted its position in UnitedHealth Group by 5.6% during the 4th quarter. Welch & Forbes LLC now owns 5,322 shares of the healthcare conglomerate's stock worth $2,692,000 after acquiring an additional 284 shares during the period. Institutional investors and hedge funds own 87.86% of the company's stock.

Insider Buying and Selling at UnitedHealth Group

In other news, Director Kristen Gil bought 3,700 shares of UnitedHealth Group stock in a transaction that occurred on Thursday, May 15th. The stock was purchased at an average cost of $271.17 per share, with a total value of $1,003,329.00. Following the completion of the transaction, the director directly owned 3,818 shares in the company, valued at $1,035,327.06. This trade represents a 3,135.59% increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Patrick Hugh Conway sold 589 shares of the stock in a transaction on Tuesday, June 10th. The shares were sold at an average price of $305.00, for a total transaction of $179,645.00. Following the completion of the transaction, the chief executive officer owned 10,398 shares of the company's stock, valued at approximately $3,171,390. This represents a 5.36% decrease in their position. The disclosure for this sale can be found here. Insiders have acquired 109,408 shares of company stock valued at $31,607,768 in the last three months. Company insiders own 0.28% of the company's stock.

UnitedHealth Group Stock Up 0.4%

UnitedHealth Group stock opened at $308.69 on Friday. The firm has a market cap of $280.03 billion, a price-to-earnings ratio of 12.93, a P/E/G ratio of 1.48 and a beta of 0.45. The firm has a fifty day moving average price of $324.99 and a two-hundred day moving average price of $447.32. UnitedHealth Group Incorporated has a fifty-two week low of $248.88 and a fifty-two week high of $630.73. The company has a debt-to-equity ratio of 0.71, a current ratio of 0.85 and a quick ratio of 0.85.

UnitedHealth Group (NYSE:UNH - Get Free Report) last released its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $7.29 by ($0.09). UnitedHealth Group had a net margin of 5.39% and a return on equity of 26.29%. The business had revenue of $109.58 billion during the quarter, compared to analyst estimates of $111.56 billion. During the same period last year, the business earned $6.91 EPS. As a group, analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, June 24th. Shareholders of record on Monday, June 16th were given a $2.21 dividend. This represents a $8.84 annualized dividend and a yield of 2.86%. This is a positive change from UnitedHealth Group's previous quarterly dividend of $2.10. The ex-dividend date was Monday, June 16th. UnitedHealth Group's dividend payout ratio (DPR) is currently 37.02%.

Wall Street Analyst Weigh In

A number of research firms have recently issued reports on UNH. TD Securities reissued a "hold" rating and issued a $308.00 price target (down from $520.00) on shares of UnitedHealth Group in a research report on Monday, May 19th. UBS Group cut their target price on shares of UnitedHealth Group from $400.00 to $385.00 and set a "buy" rating for the company in a research report on Wednesday, June 25th. Royal Bank Of Canada dropped their price target on shares of UnitedHealth Group from $525.00 to $355.00 and set an "outperform" rating on the stock in a research note on Friday, May 16th. Hsbc Global Res cut UnitedHealth Group from a "hold" rating to a "moderate sell" rating in a research report on Wednesday, May 21st. Finally, Wells Fargo & Company reiterated an "overweight" rating on shares of UnitedHealth Group in a report on Friday, June 6th. One equities research analyst has rated the stock with a sell rating, nine have given a hold rating and sixteen have given a buy rating to the company. Based on data from MarketBeat.com, the company has an average rating of "Moderate Buy" and an average price target of $415.57.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.